Cargando…
SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
BACKGROUND: Emergence of viral variants that escape CTL control is a major hurdle in HIV vaccination unless such variants affect gene regions that are essential for virus replication. Vaccine-induced multispecific CTL could also be able to control viral variants replication. To explore these possibi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1613241/ https://www.ncbi.nlm.nih.gov/pubmed/16945152 http://dx.doi.org/10.1186/1743-422X-3-65 |
_version_ | 1782130478501855232 |
---|---|
author | Villefroy, Pascale Letourneur, Franck Coutsinos, Zoe Mortara, Lorenzo Beyer, Christian Gras-Masse, Helene Guillet, Jean-Gerard Bourgault-Villada, Isabelle |
author_facet | Villefroy, Pascale Letourneur, Franck Coutsinos, Zoe Mortara, Lorenzo Beyer, Christian Gras-Masse, Helene Guillet, Jean-Gerard Bourgault-Villada, Isabelle |
author_sort | Villefroy, Pascale |
collection | PubMed |
description | BACKGROUND: Emergence of viral variants that escape CTL control is a major hurdle in HIV vaccination unless such variants affect gene regions that are essential for virus replication. Vaccine-induced multispecific CTL could also be able to control viral variants replication. To explore these possibilities, we extensively characterized CTL responses following vaccination with an epitope-based lipopeptide vaccine and challenge with pathogenic SIVmac251. The viral sequences corresponding to the epitopes present in the vaccine as well as the viral loads were then determined in every macaque following SIV inoculation. RESULTS: In most cases, the emergence of several viral variants or mutants within vaccine CTL epitopes after SIV challenge resulted in increased viral loads except for a single macaque, which showed a single escape viral variant within its 6 vaccine-induced CTL epitopes. CONCLUSION: These findings provide a better understanding of the evolution of CD8+ epitope variations after vaccination-induced CTL expansion and might provide new insight for the development of an effective HIV vaccine. |
format | Text |
id | pubmed-1613241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-16132412006-10-17 SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251 Villefroy, Pascale Letourneur, Franck Coutsinos, Zoe Mortara, Lorenzo Beyer, Christian Gras-Masse, Helene Guillet, Jean-Gerard Bourgault-Villada, Isabelle Virol J Study Protocol BACKGROUND: Emergence of viral variants that escape CTL control is a major hurdle in HIV vaccination unless such variants affect gene regions that are essential for virus replication. Vaccine-induced multispecific CTL could also be able to control viral variants replication. To explore these possibilities, we extensively characterized CTL responses following vaccination with an epitope-based lipopeptide vaccine and challenge with pathogenic SIVmac251. The viral sequences corresponding to the epitopes present in the vaccine as well as the viral loads were then determined in every macaque following SIV inoculation. RESULTS: In most cases, the emergence of several viral variants or mutants within vaccine CTL epitopes after SIV challenge resulted in increased viral loads except for a single macaque, which showed a single escape viral variant within its 6 vaccine-induced CTL epitopes. CONCLUSION: These findings provide a better understanding of the evolution of CD8+ epitope variations after vaccination-induced CTL expansion and might provide new insight for the development of an effective HIV vaccine. BioMed Central 2006-08-31 /pmc/articles/PMC1613241/ /pubmed/16945152 http://dx.doi.org/10.1186/1743-422X-3-65 Text en Copyright © 2006 Villefroy et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Villefroy, Pascale Letourneur, Franck Coutsinos, Zoe Mortara, Lorenzo Beyer, Christian Gras-Masse, Helene Guillet, Jean-Gerard Bourgault-Villada, Isabelle SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251 |
title | SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251 |
title_full | SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251 |
title_fullStr | SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251 |
title_full_unstemmed | SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251 |
title_short | SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251 |
title_sort | siv escape mutants in rhesus macaques vaccinated with nef-derived lipopeptides and challenged with pathogenic sivmac251 |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1613241/ https://www.ncbi.nlm.nih.gov/pubmed/16945152 http://dx.doi.org/10.1186/1743-422X-3-65 |
work_keys_str_mv | AT villefroypascale sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251 AT letourneurfranck sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251 AT coutsinoszoe sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251 AT mortaralorenzo sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251 AT beyerchristian sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251 AT grasmassehelene sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251 AT guilletjeangerard sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251 AT bourgaultvilladaisabelle sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251 |